JP2001500844A - プレニルトランスフェラーゼ阻害剤 - Google Patents
プレニルトランスフェラーゼ阻害剤Info
- Publication number
- JP2001500844A JP2001500844A JP10504125A JP50412598A JP2001500844A JP 2001500844 A JP2001500844 A JP 2001500844A JP 10504125 A JP10504125 A JP 10504125A JP 50412598 A JP50412598 A JP 50412598A JP 2001500844 A JP2001500844 A JP 2001500844A
- Authority
- JP
- Japan
- Prior art keywords
- lower alkyl
- pharmaceutically acceptable
- acceptable salt
- compound
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/36—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/38—Eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記式Iまたは式IIの化合物: ただし、R1は、N(R10)(R11)であり; R2は、チオ低級アルキルであり; R3及びR5は、それぞれ独立して、CH2またはC(O)であり; R4は、置換または非置換チオ低級アルキルであり、この際、置換基はCH2NH C(O)R13でありかつ前記置換基はチオ基に結合し; R6は、天然または合成α−アミノ酸の残基であり; R7は、天然または合成α−アミノ酸の残基であり; R8は、OHまたは低級アルコキシであり、またはR7と共にホモセリンラクトン を形成し; R9、R10及びR11は、それぞれ独立して、Hまたは低級アルキルであり; R12は、シクロアルキル、シクロアルキル低級アルキル、アリール、アリール低 級アルキル、複素環、及び複素環低級アルキルから選ばれる置換または非置換部 分であり、この際、置換基は低級アルキル、アリール、ハロ、低級アルコキシ、 またはC(O)−R7−R8であり; R13は、低級アルキル、アリール、またはアリール低級アルキルであり; R18は、Hまたは、R9と共に、−CH2CH2−を形成し; R4が非置換チオ低級アルキルである際には、R2及びR4の遊離チオ基 はジスルフィド結合を形成してもよい; または製薬上許容できるその塩。 2.該化合物が式Iを有する、請求の範囲第1項に記載の化合物;または製薬 上許容できるその塩。 3.該化合物が式IIを有する、請求の範囲第1項に記載の化合物;または製 薬上許容できるその塩。 4.R6が−N(R14)CH(R15)C(O)−であり、この際、R14がH若 しくは低級アルキルであり、およびR15が低級アルキル、アリール、アリール低 級アルキル、複素環、及び複素環低級アルキルから選ばれる置換若しくは非置換 部分であり、この際、置換基は低級アルキル、ハロ、または若しくは低級アルコ キシであり、またはR15は、これに結合するN(R14)Cと共に、複素環を形成 し; R7が−N(R16)CH(R17)C(O)−であり、この際、R16がH若しくは 低級アルキルであり;およびR17がmが1〜6でありかつが0〜2である(CH2 )mS(O)nCH3である、若しくは低級アルキル及びチオ低級アルキルから選 ばれる置換若しくは非置換部分であり、この際、置換基はC(O)N(R10)( R11)であり;および R8はOH若しくは低級アルコキシである、請求の範囲第2項に記載の化合物; または製薬上許容できるその塩。 5.R2がCH2SHであり;および R4がC(CH3)2SHまたはCH2SHであり; この際、R2及びR4の遊離チオ基はジスルフィド結合を形成する、請求の範囲第 4項に記載の化合物;または製薬上許容できるその塩。 6.R15が、これに結合するN(R14)Cと共に、複素環を形成し;R16がH であり;およびR17が(CH2)2S(O)nCH3である、請求の範囲第5項に記 載の化合物;または製薬上許容できるその塩。 7.R1がNH2であり; R3がCH2であり; R5がC(O)であり;および R8がOHまたはOCH3である、請求の範囲第6項に記載の化合物;または製薬 上許容できるその塩。 8.R2がCH2SHであり;および R4がC(CH3)2SCH2NHC(O)CH3またはCH2SCH2NHC(O) CH3である、請求の範囲第4項に記載の化合物;または製薬上許容できるその 塩。 9.R15が、これに結合するN(R14)Cと共に、複素環を形成し;R16がH であり;およびR17は(CH2)2S(O)nCH3である、請求の範囲第8項に記 載の化合物;または製薬上許容できるその塩。 10.R1 がはNH2であり; R3がCH2であり; R5がC(O)であり;および R8がOHまたはOCH3である、請求の範囲第9項に記載の化合物;または製薬 上許容できるその塩。 11.R2がCH2SHであり;および R4がC(CH3)2SHまたはCH2SHであり; この際、R2及びR4の遊離チオ基はジスルフィド結合を形成する、請求の範囲第 3項に記載の化合物;または製薬上許容できるその塩。 12.R12が置換または非置換アリール、または置換または非置換アリール低級 アルキルであり;およびR18がHである、請求の範囲第11項に記載の化合物; または製薬上許容できるその塩。 13.R1がNH2であり; R3がCH2であり; R5がC(O)であり; R9がHであり;および R12が置換または非置換フェニルまたはベンジルであり、この際、置換基は低級 アルキルまたはハロである、請求の範囲第12項に記載の化合物;または製薬上 許容できるその塩。 14.R2が(CH2)SHであり;および R4がC(CH3)2SCH2NHC(O)CH3またはCH2SCH2NHC(O) CH3である、請求の範囲第3項に記載の化合物;または製薬上許容できるその 塩。 15.R12が置換または非置換アリールまたはアリール低級アルキルである、請 求の範囲第14項に記載の化合物;または製薬上許容できるその塩。 16.R1がNH2であり; R3がCH2であり; R5がC(O)であり; R9がHであり;および R12が置換または非置換フェニルまたはベンジルであり、この際、置換基は低級 アルキルまたはハロである、請求の範囲第15項に記載の化合物;または製薬上 許容できるその塩。 17.該化合物が下記式を有するものである、請求の範囲第1項に記載の化合物 : 18.治療上有効量の請求の範囲第1項の化合物または塩を患者に投与すること からなる、腫瘍または再狭窄を処置する必要のある患者における腫瘍または再狭 窄の処置方法。 19.該化合物または塩が請求の範囲第17項に記載されるものである、請求の 範囲第18項に記載の方法。 20.請求の範囲第1項の化合物を含む薬剤組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/675,439 US5767274A (en) | 1996-06-28 | 1996-06-28 | Prenyl transferase inhibitors |
US08/675,439 | 1996-06-28 | ||
PCT/US1997/009413 WO1998000411A1 (en) | 1996-06-28 | 1997-05-29 | Prenyl transferase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001500844A true JP2001500844A (ja) | 2001-01-23 |
JP4073491B2 JP4073491B2 (ja) | 2008-04-09 |
Family
ID=24710505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50412598A Expired - Fee Related JP4073491B2 (ja) | 1996-06-28 | 1997-05-29 | プレニルトランスフェラーゼ阻害剤 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5767274A (ja) |
EP (2) | EP1015439B1 (ja) |
JP (1) | JP4073491B2 (ja) |
KR (1) | KR20000022305A (ja) |
CN (1) | CN1091766C (ja) |
AT (1) | ATE359290T1 (ja) |
CA (1) | CA2255893A1 (ja) |
CZ (1) | CZ296248B6 (ja) |
DE (1) | DE69737609T2 (ja) |
ES (1) | ES2283017T3 (ja) |
IL (1) | IL127575A (ja) |
NZ (1) | NZ332560A (ja) |
PL (1) | PL190852B1 (ja) |
PT (1) | PT1015439E (ja) |
RU (1) | RU2201925C2 (ja) |
TW (1) | TW503240B (ja) |
WO (1) | WO1998000411A1 (ja) |
ZA (1) | ZA975728B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5299915A (en) * | 1992-07-15 | 1994-04-05 | General Electric Corporation | Bucket for the last stage of a steam turbine |
US6180619B1 (en) * | 1996-06-28 | 2001-01-30 | Biomeasure, Incorporated | Prenyl transferase inhibitors |
US7932036B1 (en) | 2008-03-12 | 2011-04-26 | Veridex, Llc | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase |
WO2009148709A1 (en) * | 2008-04-16 | 2009-12-10 | University Of Utah Research Foundation | Pharmacological targeting of vascular malformations |
CN106244707A (zh) | 2010-07-28 | 2016-12-21 | 维里德克斯有限责任公司 | 急性髓细胞性白血病应答法尼基转移酶抑制剂治疗的测定方法 |
ES2901506T3 (es) | 2015-08-17 | 2022-03-22 | Kura Oncology Inc | Métodos para tratar pacientes con cáncer con inhibidores de la farnesiltransferasa |
PT3534885T (pt) | 2016-11-03 | 2021-04-13 | Kura Oncology Inc | Inibidores de farnesiltransferase para usar em métodos de tratamento do cancro |
WO2019113269A1 (en) | 2017-12-08 | 2019-06-13 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
US20220143006A1 (en) | 2019-03-15 | 2022-05-12 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141851A (en) * | 1990-04-18 | 1992-08-25 | Board Of Regents, The University Of Texas System | Isolated farnesyl protein transferase enzyme |
CA2118985A1 (en) * | 1993-04-02 | 1994-10-03 | Dinesh V. Patel | Heterocyclic inhibitors of farnesyl protein transferase |
AU675145B2 (en) * | 1993-06-18 | 1997-01-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5439918A (en) * | 1994-03-14 | 1995-08-08 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CA2155448A1 (en) * | 1994-08-11 | 1996-02-12 | Katerina Leftheris | Inhibitors of farnesyl protein transferase |
US5491164A (en) * | 1994-09-29 | 1996-02-13 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
-
1996
- 1996-06-28 US US08/675,439 patent/US5767274A/en not_active Expired - Fee Related
-
1997
- 1997-05-29 NZ NZ332560A patent/NZ332560A/en unknown
- 1997-05-29 AT AT97926849T patent/ATE359290T1/de not_active IP Right Cessation
- 1997-05-29 WO PCT/US1997/009413 patent/WO1998000411A1/en active IP Right Grant
- 1997-05-29 KR KR1019980710727A patent/KR20000022305A/ko not_active Application Discontinuation
- 1997-05-29 ES ES97926849T patent/ES2283017T3/es not_active Expired - Lifetime
- 1997-05-29 PL PL330786A patent/PL190852B1/pl unknown
- 1997-05-29 EP EP97926849A patent/EP1015439B1/en not_active Expired - Lifetime
- 1997-05-29 CA CA002255893A patent/CA2255893A1/en not_active Abandoned
- 1997-05-29 CN CN97195839A patent/CN1091766C/zh not_active Expired - Fee Related
- 1997-05-29 JP JP50412598A patent/JP4073491B2/ja not_active Expired - Fee Related
- 1997-05-29 IL IL12757597A patent/IL127575A/en not_active IP Right Cessation
- 1997-05-29 PT PT97926849T patent/PT1015439E/pt unknown
- 1997-05-29 CZ CZ0417898A patent/CZ296248B6/cs not_active IP Right Cessation
- 1997-05-29 DE DE69737609T patent/DE69737609T2/de not_active Expired - Fee Related
- 1997-05-29 RU RU99101793/04A patent/RU2201925C2/ru not_active IP Right Cessation
- 1997-05-29 EP EP06005859A patent/EP1676855A3/en not_active Withdrawn
- 1997-06-27 ZA ZA9705728A patent/ZA975728B/xx unknown
- 1997-06-28 TW TW086109108A patent/TW503240B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20000022305A (ko) | 2000-04-25 |
PT1015439E (pt) | 2007-05-31 |
EP1015439A1 (en) | 2000-07-05 |
ZA975728B (en) | 1998-01-26 |
CZ417898A3 (cs) | 1999-05-12 |
AU715475B2 (en) | 2000-02-03 |
US5767274A (en) | 1998-06-16 |
TW503240B (en) | 2002-09-21 |
DE69737609D1 (de) | 2007-05-24 |
IL127575A0 (en) | 1999-10-28 |
DE69737609T2 (de) | 2007-12-20 |
CA2255893A1 (en) | 1998-01-08 |
AU3151697A (en) | 1998-01-21 |
EP1676855A3 (en) | 2006-07-26 |
EP1015439A4 (en) | 2001-10-17 |
CN1223643A (zh) | 1999-07-21 |
RU2201925C2 (ru) | 2003-04-10 |
CZ296248B6 (cs) | 2006-02-15 |
ATE359290T1 (de) | 2007-05-15 |
PL190852B1 (pl) | 2006-02-28 |
WO1998000411A1 (en) | 1998-01-08 |
EP1015439B1 (en) | 2007-04-11 |
CN1091766C (zh) | 2002-10-02 |
PL330786A1 (en) | 1999-06-07 |
NZ332560A (en) | 2000-02-28 |
EP1676855A2 (en) | 2006-07-05 |
ES2283017T3 (es) | 2007-10-16 |
JP4073491B2 (ja) | 2008-04-09 |
IL127575A (en) | 2002-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0932606B1 (en) | Inhibitors of prenyl transferases | |
JP2001500844A (ja) | プレニルトランスフェラーゼ阻害剤 | |
JPH10508005A (ja) | チオールを有しないファルネシル−タンパク質トランスフェラーゼ阻害剤 | |
US6313109B2 (en) | Prenyl transferase inhibitors | |
AU715475C (en) | Prenyl transferase inhibitors | |
KR100491433B1 (ko) | 프레닐전이효소의저해제 | |
KR20050019003A (ko) | 프레닐 전이효소 저해제 | |
KR20050019004A (ko) | 프레닐 전이효소 저해제 | |
MXPA98010693A (en) | Inhibitors of the prenyl-transfer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070731 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070724 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071029 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080115 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080123 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110201 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110201 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |